THE AMPA RECEPTOR ANTAGONIST NBQX DOES NOT ALTER THE MOTOR RESPONSE INDUCED BY SELECTIVE DOPAMINE AGONISTS IN MPTP-TREATED MONKEYS

被引:40
作者
LUQUIN, MR
OBESO, JA
LAGUNA, J
GUILLEN, J
MARTINEZLAGE, JM
机构
[1] Department of Neurology, Clínica Universitaria de Navarra, Medical School, Pamplona
关键词
AMPA RECEPTORS; NBQX(2,3-DIHYDROXY-6-NITRO-7-SULFAMOYLBENZO[F]QUINOXALINE(1H,4H)DIONE SODIUM SALT); PARKINSONISM; DYSKINESIA; DOPAMINE RECEPTOR AGONISTS;
D O I
10.1016/0014-2999(93)90149-C
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the motor response induced by the administration of the AMPA receptor antagonist, NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline(1H,4H)dione sodium salt), in two parkinsonian monkeys and its interaction with the selective D-2 dopamine receptor agonist, (+)-PHNO [(+)-4-propyl-9-hydroxynaphthoxazine], and the partial dopamine D-1 receptor agonist, CY 208-243 [(-)-4,6,6a,7,8,12b-hexahydro-7-methyl-indolo[4,3a-b]phenanthyxidine]. NBQX treatment did not reverse the parkinsonism or change the responses previously induced by dopamine agonists. These results do not support an antiparkinsonian effect of the AMPA receptor antagonist, NBQX. In addition they indicate that there is no functional interaction between AMPA and dopamine receptors in monkeys with a substantia nigra lesion.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 13 条
[1]  
BERGMAN H, 1990, SCIENCE, V249, P1439
[2]   ALLEVIATION OF PARKINSONISM BY ANTAGONISM OF EXCITATORY AMINO-ACID TRANSMISSION IN THE MEDIAL SEGMENT OF THE GLOBUS-PALLIDUS IN RAT AND PRIMATE [J].
BROTCHIE, JM ;
MITCHELL, IJ ;
SAMBROOK, MA ;
CROSSMAN, AR .
MOVEMENT DISORDERS, 1991, 6 (02) :133-138
[3]   THE NMDA ANTAGONIST MK-801 CAUSES MARKED LOCOMOTOR STIMULATION IN MONOAMINE-DEPLETED MICE [J].
CARLSSON, M ;
CARLSSON, A .
JOURNAL OF NEURAL TRANSMISSION, 1989, 75 (03) :221-226
[4]   EFFECT OF THE NMDA ANTAGONIST MK-801 ON MPTP-INDUCED PARKINSONISM IN THE MONKEY [J].
CROSSMAN, AR ;
PEGGS, D ;
BOYCE, S ;
LUQUIN, MR ;
SAMBROOK, MA .
NEUROPHARMACOLOGY, 1989, 28 (11) :1271-1273
[5]  
FILION M, 1991, BRAIN RES, V547, P142
[6]   D1 AND D2 DOPAMINE RECEPTOR REGULATED GENE-EXPRESSION OF STRIATONIGRAL AND STRIATOPALLIDAL NEURONS [J].
GERFEN, CR ;
ENGBER, TM ;
MAHAN, LC ;
SUSEL, Z ;
CHASE, TN ;
MONSMA, FJ ;
SIBLEY, DR .
SCIENCE, 1990, 250 (4986) :1429-1432
[7]   THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS [J].
KLOCKGETHER, T ;
TURSKI, L ;
HONORE, T ;
ZHANG, ZM ;
GASH, DM ;
KURLAN, R ;
GREENAMYRE, JT .
ANNALS OF NEUROLOGY, 1991, 30 (05) :717-723
[8]  
KLOCKGETHER T, 1990, ANN NEUROL, V28, P39
[9]   SYNERGISM OF THE AMPA-ANTAGONIST NBQX AND THE NMDA-ANTAGONIST CPP WITH L-DOPA IN MODELS OF PARKINSONS-DISEASE [J].
LOSCHMANN, PA ;
LANGE, KW ;
KUNOW, M ;
RETTIG, KJ ;
JAHNIG, P ;
HONORE, T ;
TURSKI, L ;
WACHTEL, H ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1991, 3 (03) :203-213
[10]   NEURAL MECHANISMS UNDERLYING PARKINSONIAN SYMPTOMS BASED UPON REGIONAL UPTAKE OF 2-DEOXYGLUCOSE IN MONKEYS EXPOSED TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
MITCHELL, IJ ;
CLARKE, CE ;
BOYCE, S ;
ROBERTSON, RG ;
PEGGS, D ;
SAMBROOK, MA ;
CROSSMAN, AR .
NEUROSCIENCE, 1989, 32 (01) :213-226